Sonnet BioTherapeutics (SONN) Receives $3.4M From Warrants Exercise Jun 20, 2024 08:37AM
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds Jun 20, 2024 08:30AM
Sonnet BioTherapeutics (SONN) Announces Pricing of $4.55 Million Underwritten Public Offering Oct 25, 2023 07:32AM
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering Oct 25, 2023 07:30AM